In preclinical immunocompetent models, the HLA-G expression in human ovarian carcinoma cell lines has demonstrated an increased capacity for migration and invasion compared to their HLA-G negative counterpart in nude mouse models. Here, HLA-G is linked to ovarian carcinoma.